https://www.selleckchem.com/products/bb-94.html
The Egger's test was applied for publication bias. A total of 770 COPD participants from 11 trials that met the inclusion criteria were included. The meta-analysis showed that modified SBS could improve the exercise endurance, life quality scores of stable COPD patients, and also showed the potential benefits to pulmonary function of COPD patients than original SBS. The methodological quality of included trials may limit the conclusions that indicate that modified SBS may have a promising treatment for improving FEV /FVC and MVV, increasi
Curtir
Comentario
Compartilhar
